Fakhreddin Jamali (born May 31, 1945) is an Iranian-Canadian professor emeritus of pharmacy and pharmaceutical sciences at the University of Alberta.

[4][5] Jamali's focus has been on drugs action (pharmacodynamics) and disposition (pharmacokinetics) particularly in field of analgesics and antiinfammatory therapy.

His earlier work on the stereoselective and stereospecific therapeutic and toxicity of drugs received high peer recognition.

His group found that inflammatory conditions such as arthritis diminish response to some cardiovascular drugs despite already known increased circulatory concentrations.

[8] His group also has reported the mechanism behind the adverse cardiovascular effects of both anti-inflammatory drugs and inflammatory conditions.